The Illinois Research & Development (R&D) Tax Credit incentivizes businesses to invest in qualified research activities within the state, offsetting Illinois income tax liabilities through the Illinois Department of Revenue. Enacted under 35 ILCS 5/201(k) and extended through tax years ending on or before December 31, 2031, it aligns closely with federal IRC § 41 guidelines while focusing on Illinois-sourced innovation in sectors like manufacturing, pharmaceuticals, and technology.
Eligibility mirrors federal standards under IRC § 41 but requires Illinois-sourced activities and expenses. Businesses must demonstrate technical uncertainty in developing or improving products, processes, or software within the state.
Illinois uses a straightforward regular (incremental) method, calculating the credit as 6.5% of current-year Illinois QREs exceeding a base amount. The base is the average of QREs from the three taxable years immediately preceding the current year. If the taxpayer had no Illinois qualifying expenditures in one or more base years, those years are treated as zero, which means startups with no prior Illinois QREs typically have a base amount of 0. Only Illinois-sourced QREs qualify, ensuring alignment with in-state economic activity.
Illinois tailors its R&D credit to support large-scale innovation while emphasizing compliance for unitary filers and pass-through entities. These provisions ensure broad accessibility without refunds but with flexible carryforwards.
Real results from an Illinois-based manufacturing company
Illinois offers a 6.5% credit on qualifying research expenses (QREs) exceeding a base amount (average prior 3-year QREs), designed to encourage innovation in industries like manufacturing and tech. It aligns with federal IRC § 41 and is claimed via Schedule 1299-D. Strike Tax helps maximize your savings.
Eligible activities include developing or improving products, processes, or software involving technical uncertainty, such as engineering innovations or data processing improvements, conducted in Illinois. Strike Tax verifies eligibility against state rules.
For $1 million in incremental QREs, you could save $65,000, stackable with federal credits. Use Strike Tax’s R&D Credit Calculator for personalized estimates based on your Illinois operations.
Credits are nonrefundable but carry forward up to 5 years to offset future tax liability. Strike Tax optimizes carryforward strategies for ongoing benefits.
Corporations and fiduciaries claim the credit on Schedule 1299-D with returns such as IL-1120 and IL-1041, while individuals and pass-through entities use Schedules 1299-C and 1299-A respectively, ensuring federal compliance. No prior approval is needed, but detailed documentation is required. Strike Tax simplifies filing and documentation.
The credit was extended through tax years ending December 31, 2031, with no rate changes. Businesses should align with updated federal Section 174 amortization rules for QREs. Strike Tax tracks compliance updates.
Unitary groups file a single consolidated return, calculating the credit at the group level and allocating based on Illinois apportionment. This streamlines claims for multi-entity operations. Strike Tax handles complex allocations.
Yes, partnerships and S corporations pass credits pro-rata to owners via K-1, who apply against personal Illinois tax. Entity-level use is limited for S corps. Strike Tax ensures accurate distributive shares.
The base is the average QREs from the prior three years (Illinois-only). Startups with no history use $0 base for full credit on current expenses. Strike Tax reconstructs historical data if needed.
Pharma, manufacturing, and tech see high savings due to substantial QREs. The 6.5% rate rewards incremental growth. Strike Tax tailors claims to your sector.
Connect with us to find out how R&D tax credits can boost your organization’s bottom line.
To get an estimate of the potential value of your unclaimed R&D Tax Credits, try out our credit calculator.

Download our R&D Tax Credit Calculator for Android to see how much you can receive from your qualified R&D tax credit expenses.
Illinois offers a 6.5% credit on qualifying research expenses (QREs) exceeding a base amount (average prior 3-year QREs), designed to encourage innovation in industries like manufacturing and tech. It aligns with federal IRC § 41 and is claimed via Schedule 1299-D. Strike Tax helps maximize your savings.
Eligible activities include developing or improving products, processes, or software involving technical uncertainty, such as engineering innovations or data processing improvements, conducted in Illinois. Strike Tax verifies eligibility against state rules.
For $1 million in incremental QREs, you could save $65,000, stackable with federal credits. Use Strike Tax’s R&D Credit Calculator for personalized estimates based on your Illinois operations.
Credits are nonrefundable but carry forward up to 5 years to offset future tax liability. Strike Tax optimizes carryforward strategies for ongoing benefits.
Corporations and fiduciaries claim the credit on Schedule 1299-D with returns such as IL-1120 and IL-1041, while individuals and pass-through entities use Schedules 1299-C and 1299-A respectively, ensuring federal compliance. No prior approval is needed, but detailed documentation is required. Strike Tax simplifies filing and documentation.
The credit was extended through tax years ending December 31, 2031, with no rate changes. Businesses should align with updated federal Section 174 amortization rules for QREs. Strike Tax tracks compliance updates.
Unitary groups file a single consolidated return, calculating the credit at the group level and allocating based on Illinois apportionment. This streamlines claims for multi-entity operations. Strike Tax handles complex allocations.
Yes, partnerships and S corporations pass credits pro-rata to owners via K-1, who apply against personal Illinois tax. Entity-level use is limited for S corps. Strike Tax ensures accurate distributive shares.
The base is the average QREs from the prior three years (Illinois-only). Startups with no history use $0 base for full credit on current expenses. Strike Tax reconstructs historical data if needed.
Pharma, manufacturing, and tech see high savings due to substantial QREs. The 6.5% rate rewards incremental growth. Strike Tax tailors claims to your sector.